Correction to: RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480
An amendment to this paper has been published and can be accessed via the original article.
Main Authors: | Chen-Chen Huang, Fang-Rui Liu, Qiang Feng, Xin-Yan Pan, Shu-Ling Song, Ju-Lun Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-04-01
|
Series: | BMC Cancer |
Online Access: | https://doi.org/10.1186/s12885-021-08120-z |
Similar Items
-
RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480
by: Chen-Chen Huang, et al.
Published: (2021-03-01) -
RGD-p21Ras-scFv expressed prokaryotically on a pilot scale inhibits ras-driven colorectal cancer growth by blocking p21Ras-GTP
by: Peng Lin, et al.
Published: (2024-01-01) -
Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
by: Chung Hyo Kang, et al.
Published: (2020-12-01) -
BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumor.
by: Ting Yu, et al.
Published: (2022-01-01) -
BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumor
by: Ting Yu, et al.
Published: (2022-01-01)